Archean Chemicals
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Archean Chemical Industries is navigating a pivotal phase characterized by strategic investments in high-margin specialty chemicals and advanced materials, particularly in the bromine and semiconductor sectors. Management's recent commentary highlights a recovery in the bromine segment and stabilization of industrial salt pricing, which are crucial for revenue growth and margin recovery. The company's focus on disciplined capital allocation and operational improvements is expected to enhance profitability, despite facing near-term logistical challenges and competitive pricing pressures. Vista's financial outlook anticipates accelerating revenue growth beyond historical levels, supported by strong order visibility and long-term contracts that mitigate volatility. The expected margin stability aligns with the company's strategic pivot towards value-added products, which should bolster its competitive position. However, geopolitical tensions and supply chain disruptions remain watchpoints. Over the next 12-24 months, key opportunities include the ramp-up of bromine capacity and successful project execution in the semiconductor space, while headwinds may arise from ongoing logistics costs and market competition. Overall, Archean is well-positioned for growth, with a target price reflecting a 26% upside from current levels
Why We Like This Stock
- Management's focus on expanding bromine derivatives and entering the semiconductor market is expected to drive revenue growth
- Long-term contracts and strong order visibility provide a buffer against market volatility, supporting margin stability
- Strategic investments in advanced materials and disciplined capital allocation are likely to enhance profitability over the medium term
Things To Watch Out For
- Logistical challenges and geopolitical tensions may continue to impact operational efficiency and cost structures
- Competitive pricing pressures in the industrial salt segment could affect margins in the short term
- Execution risks associated with new project timelines and approvals may pose challenges to achieving growth targets
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,330 | 1,041 | 1,081 | 1,320 | 1,461 |
| Profit Before Tax (Cr.) | 404 | 242 | 147 | 147 | 197 |
| PBT Margin | 30.4% | 23.2% | 13.6% | 11.1% | 13.5% |
| Net Profit (Cr.) | 327 | 158 | 92 | 110 | 146 |
| Earnings Per Share | 26.4 | 12.8 | 7.5 | 8.8 | 11.9 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| ICICI Securities | ▲ Buy | 640 | 01-Sep-2026 |
| Axis Securities | ► Hold | 490 | 04-Aug-2026 |
| Deven Choksey | ► Accumulate | 588 | 04-Aug-2026 |
Company Overview
Show Company Profile
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 2003 and is based in Chennai, India.